1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. Montana >
  6. AMAG Pharmaceuticals Acquires Lumara Health

M&A Deal Summary

AMAG Pharmaceuticals Acquires Lumara Health

On September 29, 2014, AMAG Pharmaceuticals acquired life science company Lumara Health for 675M USD

Acquisition Highlights
  • This is AMAG Pharmaceuticals’ 1st transaction in the Life Science sector.
  • This is AMAG Pharmaceuticals’ 2nd largest (disclosed) transaction.
  • This is AMAG Pharmaceuticals’ 1st transaction in the United States.
  • This is AMAG Pharmaceuticals’ 1st transaction in Montana.

M&A Deal Summary
Date 2014-09-29
Target Lumara Health
Sector Life Science
Buyer(s) AMAG Pharmaceuticals
Deal Type Add-on Acquisition
Deal Value 675M USD
Advisor(s) Perella Weinberg Partners
T.R. Winston & Co. (Financial)
Dechert (Legal)

Target

Lumara Health

St. Louis, Montana, United States
Lumara Health, Inc. is a pharmaceutical company committed to advancing the health of women throughout the stages of their lives, with a particular focus on maternal health.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

AMAG Pharmaceuticals

Waltham, Massachusetts, United States
Category Company
Founded 1981
Sector Life Science
Employees440
Revenue 328M USD (2019)
DESCRIPTION

AMAG Pharmaceuticals, Inc. is a specialty pharmaceutical company that markets Feraheme (ferumoxytol) Injection and MuGard® Mucoadhesive Oral Wound Rinse. AMAG Pharmaceuticals was formed in 1981 and is based in Waltham, Massachusetts.

DEAL STATS #
Overall 1 of 3
Sector: Life Science M&A 1 of 2
Type: Add-on Acquisition M&A Deals 1 of 3
State: Montana M&A 1 of 1
Country: United States M&A 1 of 3
Year: 2014 M&A 1 of 1
Size (of disclosed) 2 of 2
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-08-17 Cord Blood Registry

San Bruno, California, United States

CBR Systems is a late-stage medical devices company with the leading market position in providing the collection, processing and cryogenically-frozen storage of stem cells.

Buy $700M
Mergr

Solution for

Product

Company

Legal